21 CFR 530 - EXTRALABEL DRUG USE IN ANIMALS
- SUBPART A — General Provisions (§§ 530.1 - 530.5)
- SUBPART B — Rules and Provisions for Extralabel Uses of Drugs in Animals (§§ 530.10 - 530.13)
- SUBPART C — Specific Provisions Relating to Extralabel Use of Animal and Human Drugs in Food-Producing Animals (§§ 530.20 - 530.25)
- SUBPART D — Extralabel Use of Human and Animal Drugs in Animals Not Intended for Human Consumption (§§ 530.30 - 530.30)
- SUBPART E — Safe Levels for Extralabel Use of Drugs in Animals and Drugs Prohibited From Extralabel Use in Animals (§§ 530.40 - 530.41)
Title 21 published on 2011-04-01
The following are only the Rules published in the Federal Register after the published date of Title 21.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
15 USC 1453 - Requirements of labeling; placement, form, and contents of statement of quantity; supplemental statement of quantity
15 USC 1454 - Rules and regulations
15 USC 1455 - Procedure for promulgation of regulations
21 USC 357 - Repealed.
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR 530
GPO FDSys XML | Text type regulations.gov FR Doc. 2012-35 RIN Docket No. FDA-2008-N-0326 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule becomes effective April 5, 2012. Submit either electronic or written comments on this document by March 6, 2012. 21 CFR Part 530 The Food and Drug Administration (FDA, the Agency) is issuing an order prohibiting certain extralabel uses of cephalosporin antimicrobial drugs in certain food-producing animals. We are issuing this order based on evidence that certain extralabel uses of these drugs in these animals will likely cause an adverse event in humans and, therefore, present a risk to the public health.
GPO FDSys XML | Text type regulations.gov FR Doc. 2012-3 RIN 0648-XA918 Docket No. FDA-2008-N-0326 DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Oceanic and Atmospheric Administration, Food and Drug Administration Final rule. The meeting will begin at 9 a.m. on Wednesday, January 25, 2012, recess at 5:30 p.m. or when business is complete; and reconvene at 9 a.m. on Thursday, January 26, 2012, and adjourn by 5:30 p.m. or when business is complete. NMFS will host a meeting of the Council Coordination Committee (CCC), consisting of the Regional Fishery Management Council chairs, vice chairs, and executive directors in January 2012. The intent of this meeting is to discuss issues of relevance to the Councils, including FY 2012 budget allocations and budget planning for FY2013 and beyond, Marine Recreational Information Program Update, Report on the Allocation of Fishery Resources, Habitat Blueprint, Managing Our Nations III Conference, and other topics related to implementation of the Magnuson-Stevens Fishery Conservation and Management Act (Magnuson-Stevens Act).



